BTK and glioblastoma: Elevated BTK expression in these TSs, which matches the high BTK expression of their corresponding tumor tissues (Fig. 1a and b), confirmed that they accurately reflect the molecular and functional characteristics of GBM and are a suitable model for evaluating drug efficacy.